Halo Pharma Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Halo Pharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013377
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Halo Pharma Inc (Halo) is a contract development and manufacturing organization which offers scientific and development expertise services. It offers project management, formulation development and analytical development services. The organization holds specialization in the development of mini and micro tablets, pellets, beads, powders, capsules, stick pack, liquid suspensions, semi-solid ointments, gels and creams, among others. Halo also offers solids, liquids and sterile ointment; and packaging services. The company offers testing services through contract development, during commercial manufacturing; and throughout the product lifecycle to support manufacturing. Its dosage forms comprise sterile, ophthalmic ointments and topical gels, non-sterile, controlled drugs, and others. Halo is headquartered in Whippany, New Jersey, the US.

Halo Pharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Halo Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 9
Asset Purchase 9
Halo Pharma Completes Acquisition Of Mirabel Manufacturing Facility From Teva Canada 9
Private Equity 10
SK Capital Acquires Majority Stake in Halo Pharma 10
Partnerships 11
ExxPharma Therapeutics Enters into Agreement with Halo Pharma 11
Acquisition 12
Halo Pharma Acquires Minority Stake In Altus Formulation 12
Halo Pharma Inc – Key Competitors 13
Halo Pharma Inc – Key Employees 14
Halo Pharma Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Corporate Communications 16
Jun 27, 2017: Halo Pharma Welcomes Itzhak Krinsky, Ph.D. to Its Board of Directors 16
Other Significant Developments 17
May 10, 2017: Halo Pharma Announces the Formation of Its Pediatric Center of Excellence for the Development, Reformulation, and Manufacturing of Drug Products in Pediatric Dosage Forms 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Halo Pharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Halo Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Halo Pharma Completes Acquisition Of Mirabel Manufacturing Facility From Teva Canada 9
SK Capital Acquires Majority Stake in Halo Pharma 10
ExxPharma Therapeutics Enters into Agreement with Halo Pharma 11
Halo Pharma Acquires Minority Stake In Altus Formulation 12
Halo Pharma Inc, Key Competitors 13
Halo Pharma Inc, Key Employees 14
Halo Pharma Inc, Subsidiaries 15

★海外企業調査レポート[Halo Pharma Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Biocodex-製薬・医療分野:企業M&A・提携分析
    Summary Biocodex (Biocodex) is a drug manufacturing company that develops and commercializes drugs. The company offers products for gastro enteric diseases, pain management, neurological and psychiatric conditions, rheumatic pains, and ENT conditions. Its products include Saccharomyces boulardii, an …
  • Racetrac Petroleum, Inc.
    Racetrac Petroleum, Inc. - Strategy, SWOT and Corporate Finance Report Summary Racetrac Petroleum, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Bestway Holdings Limited:企業の戦略・SWOT・財務情報
    Bestway Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Bestway Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Aeon Global Health Corp (ADAT)-医療機器分野:企業M&A・提携分析
    Summary Aeon Global Health Corp (Aeon), formerly Authentidate Holding Corp is a clinical lab and healthcare services organization that offers diagnostic services in cancer genomics, toxicology, pharmacogenomics, and health technology applications. The organization offers clinical laboratory services …
  • Anavex Life Sciences Corp (AVXL):企業の財務・戦略的SWOT分析
    Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • DCP Midstream LP (DCP):企業の財務・戦略的SWOT分析
    DCP Midstream LP (DCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Tecpetrol SA:企業の戦略的SWOT分析
    Tecpetrol SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • CSE Global Limited (544):石油・ガス:M&Aディール及び事業提携情報
    Summary CSE Global Limited (CSE) is a technology company offering process control systems and integrated plant communication systems. It’s process control systems offers emergency shutdown systems, process shutdown systems, integrated control & safety systems and fire and gas detection systems, well …
  • Enstar Group Ltd.:企業の戦略・SWOT・財務情報
    Enstar Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Enstar Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Standex International Corp:企業の戦略・SWOT・財務情報
    Standex International Corp - Strategy, SWOT and Corporate Finance Report Summary Standex International Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bioplus Life Sciences Private Limited:戦略・SWOT・企業財務分析
    Bioplus Life Sciences Private Limited - Strategy, SWOT and Corporate Finance Report Summary Bioplus Life Sciences Private Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Lafarge Malaysia Berhad (LAFMSIA):企業の財務・戦略的SWOT分析
    Summary Lafarge Malaysia Berhad (LMB), formerly Lafarge Malayan Cement Berhad is a construction company that manufactures and markets aggregates, ready-mixed concrete, cement, and related construction and building materials. The company offers cement products such as walcrete, rumah, phoenix, oil we …
  • Fujitsu Limited (6702):企業の財務・戦略的SWOT分析
    Fujitsu Limited (6702) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • The Higashi-Nippon Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Higashi-Nippon Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Higashi-Nippon Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • United Continental Holdings Inc:戦略・SWOT・企業財務分析
    United Continental Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary United Continental Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Lin Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lin Bioscience Inc (Lin Bioscience) is a drug development company that specializes in developing therapies for oncology, ophthalmology and other metabolic diseases. The company’s pipeline product LBS-008 is an oral therapy for treatment of macular degeneration; LBS-007 is a small molecular i …
  • AutoZone, Inc.:企業の戦略・SWOT・財務情報
    AutoZone, Inc. - Strategy, SWOT and Corporate Finance Report Summary AutoZone, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Clean TeQ Holdings Ltd (CLQ):企業の財務・戦略的SWOT分析
    Summary Clean TeQ Holdings Ltd (Clean TeQ) is a clean technology company that offers air pollution control solutions using biotechnology-based processes. The company provides water treatment products such as advanced separations, advanced oxidation, encapsulated bacteria, continuous ionic filtration …
  • Hsh Nordbank Private Banking:企業の戦略・SWOT・財務分析
    Hsh Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report Summary Hsh Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Anglo American Plc:企業の戦略・SWOT・財務情報
    Anglo American Plc - Strategy, SWOT and Corporate Finance Report Summary Anglo American Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆